Plasmapheresis in the ICU

被引:2
作者
Hussein, Guleid [1 ]
Liu, Bolun [1 ]
Yadav, Sumeet K. [1 ]
Warsame, Mohamed [1 ]
Jamil, Ramsha [2 ]
Surani, Salim R. [3 ,4 ]
Khan, Syed A. [1 ]
机构
[1] Mayo Clin Hlth Syst, Mankato, MN 56001 USA
[2] Jinnah Sindh Med Univ, Sindh Med Coll, Karachi 75510, Pakistan
[3] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA
[4] Texas A&M Univ, Dept Med & Pharmacol, College Stn, TX 77843 USA
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 12期
关键词
plasmapheresis; ICU; TPE; THERAPEUTIC PLASMA-EXCHANGE; CLINICAL-PRACTICE; ACUTE ATTACKS; DOUBLE-BLIND; APHERESIS; COMPLICATIONS; GUIDELINE; TECHNOLOGY; INFUSION; SOCIETY;
D O I
10.3390/medicina59122152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Therapeutic plasma exchange (TPE) is a treatment paradigm used to remove harmful molecules from the body. In short, it is a technique that employs a process that functions partially outside the body and involves the replacement of the patient's plasma. It has been used in the ICU for a number of different disease states, for some as a first-line treatment modality and for others as a type of salvage therapy. This paper provides a brief review of the principles, current applications, and potential future directions of TPE in critical care settings.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Factors affecting clinical outcomes of continuous and intermittent plasmapheresis in patients with severe hypertriglyceridemia
    Hussein, Eiman A.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (05) : 775 - 783
  • [32] plasmapheresis
    Oral, Mehmet
    Yilmaz, Ali Abbas
    JOURNAL OF THE TURKISH SOCIETY OF INTENSIVE CARE-TURK YOGUN BAKM DERNEGI DERGISI, 2008, 6 (01): : 19 - 24
  • [33] Plasma and plasma derivatives in therapeutic plasmapheresis
    McLeod, Bruce C.
    TRANSFUSION, 2012, 52 : 38S - 44S
  • [34] Tandem Plasmapheresis and Hemodialysis: Efficacy and Safety
    Jose Perez-Saez, Maria
    Toledo, Katia
    Ojeda, Raquel
    Crespo, Rodolfo
    Soriano, Sagrario
    Antonia Alvarez de Lara, Maria
    Martin-Malo, Alejandro
    Aljama, Pedro
    RENAL FAILURE, 2011, 33 (08) : 765 - 769
  • [35] Donor Hemovigilance during Preparatory Plasmapheresis
    Diekamp, Ulrich
    Gneissl, Johannes
    Rabe, Angela
    Kiessig, Stephan T.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (02) : 123 - 133
  • [36] The role of therapeutic plasmapheresis in patients with hyperthyroidism
    Baser, Ozden Ozdemir
    Cetin, Zeynep
    Catak, Merve
    Koseoglu, Derya
    Berker, Dilek
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (04)
  • [37] Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition
    Fox, Tilly
    Hunt, Beverley J.
    Ariens, Robert A. S.
    Towers, Greg J.
    Lever, Robert
    Garner, Paul
    Kuehn, Rebecca
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (07):
  • [38] Arteriovenous access does not perform as well for plasmapheresis
    Wooster, Mathew
    Wilson, Rachel
    Shames, Murray
    Moudgill, Neil
    JOURNAL OF VASCULAR ACCESS, 2017, 18 (02) : 144 - 147
  • [39] Changing Trends in Therapeutic Plasmapheresis: An Indian Perspective
    Tiwari, Aseem K.
    Bhardwaj, Gunjan
    Aggarwal, Geet
    Arora, Dinesh
    Dara, Ravi C.
    Acharya, Devi P.
    Gayam, Sangeetha
    Choudhuri, Jui
    THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (05) : 500 - 506
  • [40] Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid
    Mazzi, G
    Raineri, A
    Zanolli, FA
    Da Ponte, C
    De Roia, D
    Santarossa, L
    Guerra, R
    Orazi, BM
    TRANSFUSION AND APHERESIS SCIENCE, 2003, 28 (01) : 13 - 18